SAM
Satovsky Asset Management Portfolio holdings
AUM
$470M
1-Year Return
10.39%
This Quarter Return
+1.34%
1 Year Return
+10.39%
3 Year Return
+46.01%
5 Year Return
–
10 Year Return
–
AUM
$416M
AUM Growth
+$74.3M
(+22%)
Cap. Flow
+$69.8M
Cap. Flow
% of AUM
16.78%
Top 10 Holdings %
Top 10 Hldgs %
90.11%
Holding
55
New
5
Increased
39
Reduced
6
Closed
3
Top Buys
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$2.04M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
$296K |
| 3 |
Nike
NKE
|
$235K |
| 4 |
Invesco KBW Bank ETF
KBWB
|
$203K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$157K |
Sector Composition
| 1 | Financials | 5.53% |
| 2 | Technology | 4.23% |
| 3 | Communication Services | 1.48% |
| 4 | Consumer Discretionary | 0.89% |
| 5 | Healthcare | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$269B
| $386K | 0.09% |
8,123
+66
| +0.8% | +$3.14K |
|
27
Johnson & Johnson
JNJ
$429B
| $354K | 0.09% |
2,424
+19
| +0.8% | +$2.78K |
|
28
Schwab International Equity ETF
SCHF
$50.1B
| $354K | 0.09% |
18,424
+1,950
| +12% | +$37.5K |
|
29
Consolidated Edison
ED
$35.2B
| $352K | 0.08% |
3,934
+185
| +5% | +$16.5K |
|
30
Pfizer
PFE
$139B
| $347K | 0.08% |
12,402
+285
| +2% | +$7.97K |
|
31
iShares Core MSCI EAFE ETF
IEFA
$149B
| $333K | 0.08% |
4,588
+168
| +4% | +$12.2K |
|
32
McDonald's
MCD
$227B
| $302K | 0.07% |
1,183
+7
| +0.6% | +$1.78K |
|
33
iShares 0-5 Year TIPS Bond ETF
STIP
$12.6B
| $273K | 0.07% |
2,743
+38
| +1% | +$3.78K |
|
34
Vanguard Value ETF
VTV
$143B
| $272K | 0.07% |
1,696
+173
| +11% | +$27.8K |
|
35
Southern Company
SO
$101B
| $261K | 0.06% |
3,363
+30
| +0.9% | +$2.33K |
|
36
Applied Materials
AMAT
$126B
| $257K | 0.06% |
1,089
+2
| +0.2% | +$472 |
|
37
SPDR Gold Trust
GLD
$110B
| $242K | 0.06% |
1,124
| – | – |
|
38
Dimensional International Core Equity Market ETF
DFAI
$11.2B
| $238K | 0.06% |
8,005
+101
| +1% | +$3K |
|
39
Mondelez International
MDLZ
$79B
| $237K | 0.06% |
3,621
+22
| +0.6% | +$1.44K |
|
40
Novo Nordisk
NVO
$250B
| $236K | 0.06% |
1,653
+9
| +0.5% | +$1.28K |
|
41
JPMorgan Chase
JPM
$832B
| $235K | 0.06% |
1,162
+5
| +0.4% | +$1.01K |
|
42
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $231K | 0.06% |
+4,677
| New | +$231K |
|
43
AT&T
T
$211B
| $230K | 0.06% |
+12,052
| New | +$230K |
|
44
Labcorp
LH
$22.7B
| $225K | 0.05% |
1,105
+4
| +0.4% | +$814 |
|
45
Warner Bros
WBD
$28.8B
| $225K | 0.05% |
30,175
+1,862
| +7% | +$13.9K |
|
46
Bristol-Myers Squibb
BMY
$95.9B
| $218K | 0.05% |
5,249
+69
| +1% | +$2.87K |
|
47
Gilead Sciences
GILD
$141B
| $211K | 0.05% |
3,077
+34
| +1% | +$2.33K |
|
48
Enterprise Products Partners
EPD
$68.9B
| $209K | 0.05% |
7,224
+127
| +2% | +$3.68K |
|
49
Vanguard Small-Cap Value ETF
VBR
$31.3B
| $203K | 0.05% |
+1,112
| New | +$203K |
|
50
Oracle
ORCL
$623B
| $201K | 0.05% |
+1,421
| New | +$201K |
|